Archives
-
Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels
2026-09-09
This study established a comparative toxicity profile for sulfamonomethoxine across algae, cladocerans, and fish-relevant aquatic testing, combining short-term and chronic endpoints. Its central finding was that microalgae were more sensitive than cladocerans, highlighting the importance of trophic-level selection when evaluating antibiotic residues in aquaculture-impacted waters.
-
Bifendate (DDB): A Systems-Level Assay Guide
2026-09-08
Bifendate (DDB) is a hepatoprotective research compound whose lipid, autophagy, and multiomics effects require carefully matched endpoints. This guide translates its molecular profile into practical assay decisions while distinguishing mechanistic evidence from translational limitations.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-09-08
Hao et al. developed ICG-loaded zirconium MOF nanoparticles functionalized with the PD-1/PD-L1 blocking polypeptide AUNP12 through a disulfide-linked, copper-free click chemistry strategy. The platform couples glutathione-responsive immunomodulator release with near-infrared photothermal therapy, offering a mechanistic approach for improving tumor-cell killing and immune activation beyond single photothermal treatment.
-
BMS-777607: c-Met Inhibitor Workflow Guide
2026-09-07
BMS-777607 supports precise MET signaling pathway inhibition in cancer metastasis models and can also serve as an exploratory perturbation in megakaryocyte maturation assays. This guide connects validated c-Met pharmacology with optimized hiPSC-derived platelet workflows while separating established evidence from practical assay recommendations.
-
DOPE Workflows for Delivery and Lipid-Death Assays
2026-09-07
DOPE combines acid-responsive membrane fusion with a practical role in nucleic acid delivery, making it useful for liposome, LNP, and transfection workflows. This guide also shows how to use DOPE carefully in Magnaporthe oryzae conidial-death assays without confusing a lipid-rescue phenotype with proof of a direct ferroptosis mechanism.
-
HyperScribe All in One mRNA Synthesis Kit Workflow
2026-09-05
Build translation-ready, ARCA-capped and polyadenylated transcripts for vaccine, translation, antisense, and RNAi studies with one integrated workflow. This guide separates product-supported specifications from recommended starting conditions and shows how to troubleshoot yield, integrity, and expression problems.
-
MAPK10–KRT16 Axis in NSCLC Metastasis
2026-09-04
The reference study identifies MAPK10 as a metastasis-suppressive kinase that phosphorylates KRT16 at Ser356 and Ser397, enabling RNF213-mediated ubiquitination and proteasomal degradation. Cellular, animal, and clinical data support the MAPK10/KRT16/RNF213 axis as a mechanistic framework for understanding NSCLC dissemination and developing prognostic biomarkers, although further validation is needed.
-
Autophagy and Resveratrol-Induced Apoptosis in RCC
2026-09-04
Yao, Fan, and He showed that resveratrol induces ROS-associated mitochondrial damage and caspase-3-dependent apoptosis in renal cell carcinoma 786-O cells, while simultaneously activating JNK-linked autophagy. The study’s central insight is that autophagy functions as a protective response, suggesting that combining resveratrol with autophagy inhibition may intensify tumor-cell death, although validation beyond this in vitro model is needed.
-
Dextrose (D-glucose) as a Metabolic Assay Variable
2026-09-03
Dextrose (D-glucose) is more than a routine nutrient: it is a controllable variable for studying hypoxia, metabolic competition, and immune-cell function. This guide translates recent tumor immunometabolism insights into rigorous assay-design decisions and practical handling recommendations.
-
ABT-199: Selective BCL-2 Inhibitor Assays
2026-09-03
A scenario-based guide to using ABT-199 (GDC-0199), Bcl-2 inhibitor, potent and selective (SKU A8194) in viability, cytotoxicity, and apoptosis assays. It connects mechanism, dose design, solvent control, data interpretation, and practical product-selection criteria for reproducible hematologic research.
-
Carbohydrate-Decorated Nanoparticles for Macrophages
2026-09-02
Chen and colleagues developed biodegradable nanoparticles that combine a cationic lipid-like component with carbohydrate-decorated PLGA or PLGA-PEG to improve macrophage uptake and gene delivery. Mannose and dextran produced particularly informative targeting and mRNA-transfection responses, supporting carbohydrate presentation as a tunable variable rather than a generic surface modification.
-
CDK4/6–BET Synergy in Pancreatic Cancer
2026-09-02
Gu et al. show that combining the CDK4/6 inhibitor palbociclib with the BET inhibitor JQ1 suppresses pancreatic ductal adenocarcinoma more effectively than either agent alone. The study links this effect to GSK3β-mediated Wnt/β-catenin regulation and reversal of the epithelial-to-mesenchymal transition, while highlighting a metastasis-related liability of CDK4/6 monotherapy.
-
HIDEN, IMP1, and FZD5 in Endoderm Differentiation
2026-09-01
Lu et al. identify HIDEN as a gene-desert lncRNA that supports human definitive endoderm differentiation by facilitating IMP1-dependent stabilization of FZD5 mRNA. The study links a distal noncoding transcript to WNT signaling and provides a framework for investigating lncRNA-mediated post-transcriptional regulation during stem-cell differentiation.
-
Pathogen-Adaptive Clues to Macrophage Bacterial Killing
2026-09-01
Russell et al. show that immune-adaptive variation in hypervirulent Streptococcus pneumoniae can reveal macrophage pathways that impose selective pressure on bacterial pathogens. Their validation of ACOD1/itaconate, NAMPT, and P2RX7, together with clemastine-mediated enhancement of phagolysosomal killing, provides a framework for identifying host-directed therapies against gram-positive infections.
-
Luminescent ATP Cell Viability Kit for Ferroptosis
2026-08-31
Use rapid ATP-based luciferase luminescence detection to quantify surviving cells in ferroptosis, proliferation, and cytotoxicity experiments. This practical workflow shows how the Luminescent ATP Cell Viability Assay Kit I can add sensitive, high-throughput viability data to mechanistic studies of ciprofloxacin and RSL3.